Building and Evolving a Chiral Control Strategy for Accelerated COVID Programs
- 8 November 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (12) , 4444-4454
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 19 references indexed in Scilit:
- Synthesis of Nirmatrelvir: Development of a Scalable Cobalt-Catalyzed Cyclopropanation for Manufacture of the Bicyclic [3.1.0]Proline-Building BlockOrganic Process Research & Development, 2023
- Synthesis of Nirmatrelvir: Development of an Efficient, Scalable Process to Generate the Western FragmentOrganic Process Research & Development, 2023
- Synthesis of Nirmatrelvir: Development of Magnesium Sulfate-Mediated Aminolysis for the Manufacture of the Eastern FragmentOrganic Process Research & Development, 2023
- Synthesis of Nirmatrelvir: Design and Optimization of an Efficient Telescoped Amidation–Dehydration SequenceOrganic Process Research & Development, 2023
- Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 MonthsACS Central Science, 2023
- Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19Organic Process Research & Development, 2023
- Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and ComedicationsClinical Pharmacology & Therapeutics, 2022
- The Path to PaxlovidACS Central Science, 2022
- An efficient synthesis of a key intermediate for the preparation of the rhinovirus protease inhibitor AG7088 via asymmetric dianionic cyanomethylation of N-Boc-l-(+)-glutamic acid dimethyl esterTetrahedron Letters, 2001
- 1,3-Asymmetric induction in dianionic allylation reactions of amino acid derivatives-synthesis of functionally useful enantiopure glutamates, pipecolates and pyroglutamatesTetrahedron Letters, 1998